Gujarat Ambuja Exports Ltd
Gujarat Ambuja Exports is engaged in the manufacturing of Corn Starch Derivatives, Soya Derivatives, Feed Ingredients, Cotton Yarn, and Edible Oils. Since its incorporation in 1991, GAEL strives to serve the Food, Pharmaceutical, Feed, and many other industries with a long-term growth strategy in the Agro-Processing sector. (Source: Company Website)
- Market Cap ₹ 5,314 Cr.
- Current Price ₹ 116
- High / Low ₹ 157 / 98.7
- Stock P/E 21.3
- Book Value ₹ 65.5
- Dividend Yield 0.30 %
- ROCE 11.5 %
- ROE 8.64 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 3.86% over past five years.
- Company has a low return on equity of 11.9% over last 3 years.
- Dividend payout has been low at 3.17% of profits over last 3 years
- Working capital days have increased from 88.0 days to 133 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Miscellaneous
Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,953 | 2,122 | 3,016 | 3,092 | 2,531 | 2,736 | 3,817 | 4,705 | 4,670 | 4,909 | 4,927 | 4,613 | |
1,814 | 2,016 | 2,821 | 2,897 | 2,367 | 2,549 | 3,527 | 4,171 | 3,983 | 4,433 | 4,484 | 4,212 | |
Operating Profit | 140 | 106 | 194 | 195 | 165 | 188 | 289 | 535 | 687 | 476 | 443 | 401 |
OPM % | 7% | 5% | 6% | 6% | 6% | 7% | 8% | 11% | 15% | 10% | 9% | 9% |
16 | 5 | 9 | 10 | 9 | 10 | 2 | 27 | 54 | 73 | 144 | 82 | |
Interest | 13 | 21 | 22 | 21 | 15 | 10 | 9 | 6 | 6 | 13 | 18 | 17 |
Depreciation | 25 | 30 | 37 | 47 | 61 | 65 | 101 | 103 | 97 | 95 | 121 | 126 |
Profit before tax | 118 | 61 | 145 | 137 | 98 | 123 | 181 | 452 | 638 | 441 | 448 | 341 |
Tax % | 21% | 18% | 22% | 19% | 14% | 16% | 20% | 25% | 26% | 25% | 23% | 27% |
93 | 50 | 113 | 111 | 84 | 104 | 146 | 338 | 475 | 330 | 346 | 249 | |
EPS in Rs | 1.68 | 0.90 | 2.04 | 2.01 | 1.52 | 1.87 | 3.18 | 7.37 | 10.36 | 7.20 | 7.54 | 5.44 |
Dividend Payout % | 9% | 17% | 10% | 9% | 14% | 11% | 8% | 4% | 3% | 5% | 0% | 5% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 4% |
3 Years: | 0% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | -19% |
TTM: | -28% |
Stock Price CAGR | |
---|---|
10 Years: | 29% |
5 Years: | 33% |
3 Years: | -7% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 12% |
Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 28 | 28 | 28 | 28 | 28 | 28 | 23 | 23 | 23 | 23 | 46 | 46 |
Reserves | 480 | 528 | 628 | 729 | 800 | 889 | 1,304 | 1,634 | 2,095 | 2,411 | 2,723 | 2,956 |
232 | 361 | 183 | 401 | 309 | 329 | 160 | 165 | 281 | 229 | 199 | 229 | |
255 | 223 | 364 | 154 | 148 | 176 | 250 | 341 | 354 | 289 | 342 | 356 | |
Total Liabilities | 995 | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,163 | 2,753 | 2,952 | 3,310 | 3,587 |
299 | 289 | 458 | 479 | 543 | 562 | 787 | 731 | 771 | 1,042 | 1,037 | 1,179 | |
CWIP | 45 | 169 | 38 | 64 | 63 | 101 | 12 | 106 | 246 | 87 | 153 | 235 |
Investments | 78 | 44 | 44 | 42 | 52 | 73 | 22 | 180 | 714 | 650 | 840 | 938 |
573 | 638 | 662 | 727 | 626 | 686 | 915 | 1,146 | 1,022 | 1,172 | 1,280 | 1,234 | |
Total Assets | 995 | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,163 | 2,753 | 2,952 | 3,310 | 3,587 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
59 | -4 | 294 | -120 | 253 | 135 | 241 | 297 | 596 | 241 | 213 | 341 | |
-94 | -95 | -79 | -73 | -130 | -130 | -60 | -302 | -777 | -72 | -253 | -336 | |
37 | 96 | -209 | 187 | -124 | -3 | -97 | 2 | 100 | -76 | -55 | -13 | |
Net Cash Flow | 3 | -2 | 6 | -6 | -0 | 2 | 84 | -3 | -81 | 93 | -95 | -8 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 21 | 30 | 13 | 18 | 16 | 23 | 15 | 17 | 18 | 21 | 24 | 28 |
Inventory Days | 88 | 79 | 67 | 75 | 82 | 73 | 74 | 77 | 76 | 69 | 81 | 78 |
Days Payable | 41 | 29 | 40 | 10 | 12 | 14 | 17 | 18 | 21 | 15 | 18 | 17 |
Cash Conversion Cycle | 68 | 79 | 41 | 83 | 86 | 82 | 72 | 76 | 73 | 75 | 87 | 89 |
Working Capital Days | 60 | 71 | 36 | 69 | 70 | 69 | 56 | 56 | 52 | 60 | 70 | 133 |
ROCE % | 19% | 10% | 19% | 15% | 9% | 11% | 28% | 30% | 18% | 16% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 May - Newspaper Publication of Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March, 2025
-
Communication To The Members Of The Company Regarding Financial Results For The Forth Quarter And Financial Year Ended 31St March, 2025
17 May - Audited FY25 results announced; final dividend of 25% recommended, subject to shareholder approval.
-
Corporate Action-Board approves Dividend
17 May - Audited FY25 results approved; final dividend 25% proposed; subsidiary acquisition noted.
-
Submission Of Audited Standalone And Consolidated Financial Results For The Financial Year Ended 31St March, 2025
17 May - Approved FY25 audited results; recommended 25% final dividend; acquired Maiz Citchem subsidiary.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 17Th May, 2025
17 May - Audited FY25 results approved; final dividend 25% recommended; Maiz Citchem acquired as subsidiary.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Segments